![]() ![]() After submission, authors cannot submit their manuscripts to other journals. The signature of the CTA is a condition of publication and papers will not be passed to the publisher for production unless a signed form has been received. He/she must have given approval of the submitted and final versions.Ĭopyright Transfer Agreement: Eur Rev Med Pharmacol Sci Authors will be required to sign a Copyright Transfer Agreement(click to download PDF) for all papers accepted for publication.He/she must have drafted the paper or revised it critically.He/she must have made a substantial contribution to research design, or to the acquisition, analysis or interpretation of data.AuthorshipĪuthors must fulfill the following criteria: The submission process requires a full declaration of the personal interests of all Authors and funding interests these details should also be included in the text of the manuscript (see below). Articles without this requirement won’t be considered for evaluation or publication. Corresponding Authors should provide an institutional and verified email address. The correspondence for each article must be carried on only by the corresponding author. Papers must be submitted exclusively to the Journal, and are accepted on the understanding that they have not been, and won’t be, published elsewhere. Submitted papers should be well formatted in grammatically correct English. Authors should also provide all supplementary information required to understand and verify the research presented in the article. Manuscript SubmissionĪuthors should submit manuscripts including figures to the Eur Rev Med Pharmacol Sci – please read and apply the loading instructions given on this website, noting that all information entered during the submission process related to the manuscript should also be included, and be identical to the final submitted version of the manuscript – please see full details under “Presentation of Manuscripts”. By submitting your manuscript to the journal you accept that your manuscript may be screened for plagiarism against previously published work. Please note that the journal employs a plagiarism detection system. The structured abstract must not exceed 200 words. ![]() Short Reports and Case Reports will be considered for publication only if of particular interest and accompanied by a short review. Letters are restricted to the discussion of papers already published in the journal, with a maximum of 300 words, one table or figure, and up to ten references. European Review for Medical and Pharmacological Sciences doesn’t accept for the publication “data not shown” or “unpublished data”. Reviews should include systematic revision of the literature concerning the treated topics and preferably meta-analyses, original illustrations, and tables. Eur Rev Med Pharmacol Sci is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety, and meta-analyses. It publishes Editorials, Reviews, Original Papers, and Scientific Correspondence on subjects regarding Experimental, Laboratory and Clinical Medicine, and Pharmacology. It upholds a peer-reviewed, rapid, and rigorous original manuscript handling and editorial process. ISI Journal Citation Reports ® Ranking: 2016, Pharmacology & PharmacyĮuropean Review for Medical and Pharmacological Sciences (Eur Rev Med Pharmacol Sci) is an open-access journal. Upload the Copyright Transfer when you submit the article. Our Journal uses certified plagiarism checker software (iThenticate® and Grammarly®) to verify the authenticity of articles and detect duplications from each article content online against billions of web pages. Note: articles sent by e-mail will not be accepted. Please, submit your manuscript to Publishing Manager. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |